https://www.thisislocallondon.co.uk/news/national/

New Post Public Reply Private Reply Replies (0) Message Board
Crunch55
725
https://www.thisislocallondon.co.uk/news/nati...-19-cases/


Love Local Jobs Homes Motoring Book an ad Local listings Local info Contact us
This Is Local London
NewsSportYoung ReporterVideo

This Is Local LondonMENU
NewsUK News18th January
Lateral flow tests detect more than 37,000 asymptomatic Covid-19 cases
By Press Association 2021
Woman tested at Covid-19 facility
Woman tested at Covid-19 facility

0 comment
More than 37,000 people with a symptomless Covid-19 infection have been detected through rapid lateral flow testing, the chief medical adviser for NHS Test and Trace has said.

Dr Susan Hopkins said the devices, which can give results in less than 30 minutes, were being rolled out across the country to enable those with no coronavirus symptoms to be tested.

Lateral flow tests are regularly used by NHS staff and were the main method of testing during a mass pilot scheme in Liverpool, but some experts have questioned their accuracy.


Coronavirus Mon Jan 18, 2021
Dr Susan Hopkins said the devices will continue to be rolled out (Hannah McKay/PA)
Dr Hopkins was asked at a Downing Street press briefing on Monday about the availability of the devices for teachers and supermarket workers who are yet to receive the Covid-19 vaccine.

She said: “We are rolling out lateral flow devices throughout the country through community testing sites and also in workplaces to allow people to get tested where they are asymptomatic to reduce the spread of disease.

“We’ve detected more than 37,000 individuals through lateral flow tests over the last number of weeks and we will continue to roll them out rapidly as an additional tool to help get this virus under control.”

There are two main types of test being used in Britain to detect cases of Covid-19.

PCR tests are swab tests of the nose and throat, which are assessed in a lab setting.

Lateral flow devices are quick turnaround tests, which can be performed without the need for laboratory assessment.

Jon Deeks, professor of biostatistics at the University of Birmingham, has previously argued people should not be told that lateral flow tests are “better than they are”.

The lead researcher of the Cochrane Review of Covid-19 diagnostic tests called for the Government to highlight the message that a negative test does not exclude disease.



Prof Deeks told Sky News that the lateral flow tests in Liverpool “missed 60% of the cases which would have been picked up by PCR”.

He said: “I think there’s an anxiety that, if we tell people the truth as to how bad this test is, people won’t bother getting it.

“But we have to do the truth – we can’t tell people that the test is better than it is.”

It came as an article published in The BMJ called for the Government to rethink the rollout of the lateral flow tests.

The article, published in the journal by Prof Deeks and colleagues, said extending the programme – which could potentially involve at-home use – could cause “serious harm”.

“We call on the Government urgently to change course,” the authors wrote.

They added: “Low test accuracy would be less dangerous if people being tested and the public at large received accurate information about the risks and implications of a false negative result.

“Instead they are being misled.”

Lateral flow devices used by the UK Government go through a rigorous evaluation by the country’s leading scientists, a Department of Health and Social Care spokesperson said.

0 comment
Promoted Stories
Rheumatologist: CBD Gummies breakthrough against joint pain
CBD HEMP GUMMIES
|
SPONSORED
Brackendale Casino Insider Exposes A Legal Trick That Can't Be Stopped
YUKON
|
SPONSORED
Finally A Reusable Mask That Will Not Fog Your Glasses
SMART COVER
|
SPONSORED
Why Are People Snapping Up This New CBD Oil?
HEMP MAX LAB CBD
|
SPONSORED
Tackling digital poverty: Power to Connect by Selin Akdemir, Francis Holland School
THIS IS LOCAL LONDON
London's route out - The Vaccine - Christopher Payne, Sutton Grammar School
THIS IS LOCAL LONDON


Get involved with the news in your community

Send your stories and photos now

entertainment
18th January
Woman ruled dead in 2017 fights to be declared alive
By Press Association 2021
Woman ruled dead in 2017 fights to be declared alive
Woman ruled dead in 2017 fights to be declared alive

Jeanne Pouchain’s status came about after a legal dispute with an employee of her former cleaning company.

Continue reading
entertainment
18th January
Four million given first vaccine dose but PM warns Covid situation ‘precarious’
By Press Association 2021
Four million given first vaccine dose but PM warns Covid situation ‘precarious’
Four million given first vaccine dose but PM warns Covid situation ‘precarious’

Boris Johnson said any easing of lockdown would be gradual once the vaccine programme had made progress.

Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

Kohat University Teams Up with MindHYVE.ai for AI Learning

Updated Category News Views 283

Kohat University Partners with MindHYVE.ai to Innovate Education In a significant advancement for higher education in the region, Kohat University of Science & Technology (KUST) has established a strategic partnership with MindHYVE.ai™. This collaboration aims to introduce ArthurAI™, an advanced learning platform that utilizes agentic AI technology, into its academic...

Continue Reading
Lulus Enhances Market Reach Through Innovative Collaborations

Updated Category News Views 336

Expanding Market Reach Through Strategic Collaborations LOS ANGELES, A prominent player in the fashion industry, Lulus is taking significant steps to enhance its market presence and reach customers in new and exciting ways. By initiating collaborations with various platforms, Lulus is keen on tapping into emerging retail channels and broadening its accessibility....

Continue Reading
Explore Top Gardening Trends for Fall by Calloway's Nursery

Updated Category News Views 172

Embracing Fall Gardening Trends with Calloway's Nursery As the seasons change, so does the opportunity to refresh our gardens and outdoor spaces. Calloway's Nursery is here to help you embrace the beauty of fall gardening. The nursery’s offerings are tailored to inspire Texans to create vibrant and inviting spaces. Fantastic Fall Container Gardens Container gardens are...

Continue Reading
happyactually Strengthens Leadership with Dr. Andia Shahzadi

Updated Category News Views 119

happyactually Appoints Dr. Andia Shahzadi as Chief Medical Officer happyactually, an innovative wellbeing technology firm, proudly announces the elevation of Dr. Andia Shahzadi to the position of Chief Medical Officer and Founding Member of the team. This change marks a significant step in the company's aim to empower life-conscious individuals through scientifically...

Continue Reading
Surrozen to Showcase Innovations at Investor Conference Soon

Updated Category News Views 76

Surrozen Announces Presentation at Healthcare Investor Conference Recently, Surrozen, Inc. (Nasdaq: SRZN), a pioneering biotechnology company based in South San Francisco, revealed that its management team will be presenting at an upcoming healthcare investor conference. The company specializes in targeted therapeutics that focus on selectively modulating the Wnt pathway,...

Continue Reading